|
JP4324480B2
(ja)
|
2002-03-26 |
2009-09-02 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
|
|
DE602004027171D1
(de)
*
|
2003-04-11 |
2010-06-24 |
High Point Pharmaceuticals Llc |
Verbindungen mit Aktivität an der 11Beta-Hydroxasteroiddehydrogenase
|
|
SE0301232D0
(sv)
*
|
2003-04-25 |
2003-04-25 |
Astrazeneca Ab |
Novel use
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
US7563905B2
(en)
|
2004-03-12 |
2009-07-21 |
Wyeth |
Triazole derivatives and method of using the same to treat HIV infections
|
|
US7795272B2
(en)
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
CA2565630C
(en)
|
2004-05-07 |
2013-05-28 |
Janssen Pharmaceutica N.V. |
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
CA2576971A1
(en)
*
|
2004-08-20 |
2006-03-02 |
Entremed, Inc. |
Compositions and methods comprising proteinase activated receptor antagonists
|
|
MY141198A
(en)
|
2004-08-30 |
2010-03-31 |
Janssen Pharmaceutica Nv |
Tricyclic adamantylamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
CN101300005B
(zh)
*
|
2004-08-30 |
2013-05-01 |
詹森药业有限公司 |
作为11-β羟类固醇脱氢酶抑制剂的N-2金刚烷基-2-苯氧基-乙酰胺衍生物
|
|
DE602005017159D1
(de)
|
2004-08-30 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Oxysteroid-dehydrogenase-inhibitoren
|
|
EP1807080A1
(en)
*
|
2004-10-29 |
2007-07-18 |
AstraZeneca AB |
Use of unsaturated quionoline or naphtalene derivatives as medicaments
|
|
ES2594874T3
(es)
|
2004-11-18 |
2016-12-23 |
Synta Pharmaceuticals Corp. |
Compuestos de triazol que modulan la actividad de HSP90
|
|
PE20060776A1
(es)
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
|
|
WO2006106052A1
(en)
|
2005-04-05 |
2006-10-12 |
F. Hoffmann-La Roche Ag |
Pyrazoles
|
|
KR100970294B1
(ko)
*
|
2005-06-08 |
2010-07-15 |
니뽄 다바코 산교 가부시키가이샤 |
복소환 화합물
|
|
MX2007015863A
(es)
*
|
2005-06-17 |
2008-04-02 |
Apogee Biotechnology Corp |
Inhibidores de esfingosina cinasa.
|
|
CA2618628C
(en)
|
2005-08-18 |
2014-11-18 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
US7622492B2
(en)
|
2005-08-31 |
2009-11-24 |
Hoffmann-La Roche Inc. |
Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
|
|
TW200734313A
(en)
*
|
2006-01-17 |
2007-09-16 |
Astrazeneca Ab |
Piperazines and piperidines as mGluR5 potentiators
|
|
WO2007082808A2
(en)
|
2006-01-18 |
2007-07-26 |
F. Hoffmann-La Roche Ag |
Thiazoles as 11 beta-hsd1 inhibitors
|
|
CN101405270B
(zh)
|
2006-03-22 |
2013-01-16 |
霍夫曼-拉罗奇有限公司 |
作为11-β-HSD-1的吡唑类
|
|
EP1998760A2
(en)
*
|
2006-03-30 |
2008-12-10 |
James E. Summerton |
Non peptidic molecules for detecting and treating tumors
|
|
RU2303597C1
(ru)
*
|
2006-05-12 |
2007-07-27 |
Иващенко Андрей Александрович |
Фармацевтическая композиция, способы ее получения и применения
|
|
US8034834B2
(en)
|
2006-05-25 |
2011-10-11 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders with HSP90 inhibitors
|
|
TWI490212B
(zh)
|
2006-05-25 |
2015-07-01 |
Synta Pharmaceuticals Corp |
調節ｈｓｐ９０活性之三唑化合物
|
|
TW200823215A
(en)
|
2006-08-04 |
2008-06-01 |
Merz Pharma Gmbh & Amp Co Kgaa |
Pyrazolopyrimidines, a process for their preparation and the use as a medicine
|
|
US8115005B2
(en)
|
2006-08-04 |
2012-02-14 |
Decode Genetics Ehf. |
Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
|
|
BRPI0719122A2
(pt)
|
2006-08-24 |
2013-12-10 |
Novartis Ag |
Compostos orgânicos
|
|
US7727978B2
(en)
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
WO2008029168A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
|
MX2009003080A
(es)
|
2006-09-22 |
2009-04-02 |
Novartis Ag |
Compuestos organicos heterociclicos.
|
|
CA2664682C
(en)
*
|
2006-10-17 |
2012-12-04 |
Reva Medical, Inc. |
N-substituted monomers and polymers
|
|
MX2009005264A
(es)
|
2006-12-06 |
2009-05-28 |
Boehringer Ingelheim Int |
Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
|
|
AU2007336238A1
(en)
|
2006-12-20 |
2008-06-26 |
Novartis Ag |
2-substituted 5-membered heterocycles as SCD inhibitors
|
|
ZA200904916B
(en)
|
2007-02-23 |
2010-09-29 |
High Point Pharmaceuticals Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2146952A1
(en)
|
2007-02-23 |
2010-01-27 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
US20110003856A1
(en)
|
2007-02-23 |
2011-01-06 |
Soren Ebdrup |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
CA2681582C
(en)
*
|
2007-03-30 |
2015-07-14 |
Amgen Inc. |
Methods of treating bowel disorders
|
|
WO2008121126A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Summerton James E |
Non-peptidic molecules for detecting and treating tumors
|
|
WO2008134035A1
(en)
*
|
2007-04-27 |
2008-11-06 |
Panacos Pharmaceuticals, Inc. |
Alpha-unsubstituted arylmethyl piperazine pyrazolo[1,5-a] pyrimidine amide derivatives
|
|
AU2008277783B2
(en)
|
2007-07-17 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Inhibitors of 11beta-hydroxysteroid dehydrogenase
|
|
JP2010534665A
(ja)
*
|
2007-07-25 |
2010-11-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルココルチコイドミメチックス、それらの製造方法、医薬組成物、及びこれらの使用
|
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
FR2929851B1
(fr)
*
|
2008-04-09 |
2012-11-30 |
Centre Nat Rech Scient |
Molecules inhibant une voie metabolique impliquant la proteine tyrosine kinase syk et procede d'identification de ces molecules
|
|
DK2300472T3
(da)
|
2008-06-06 |
2012-04-10 |
Boehringer Ingelheim Int |
Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf
|
|
MY154000A
(en)
*
|
2008-09-22 |
2015-04-30 |
Cayman Chem Co |
Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
|
SI2350075T1
(sl)
|
2008-09-22 |
2014-06-30 |
Array Biopharma, Inc. |
Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
|
|
CN102264736B
(zh)
|
2008-10-22 |
2013-08-14 |
阵列生物制药公司 |
作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010051206A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
BRPI0921299A2
(pt)
|
2008-11-21 |
2015-08-25 |
High Point Pharmaceuticals Llc |
Compostos de benzamida adamantila
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
EP2947073B1
(en)
*
|
2009-10-22 |
2019-04-03 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
US9205086B2
(en)
|
2010-04-19 |
2015-12-08 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
|
|
BR122019024201B1
(pt)
|
2010-05-20 |
2021-08-03 |
Array Biopharma Inc |
Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
|
|
AU2011202542A1
(en)
*
|
2010-07-14 |
2012-02-02 |
Indian Institute Of Science |
Benzothiophene carboxamide compounds, composition and applications thereof
|
|
FR2962649B1
(fr)
*
|
2010-07-19 |
2025-10-24 |
Conservatoire Nat Arts Et Metiers |
Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide
|
|
US8513430B2
(en)
|
2010-07-27 |
2013-08-20 |
High Point Pharmaceuticals, Llc |
Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
WO2013067162A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
|
|
AU2012332424A1
(en)
|
2011-11-02 |
2014-06-05 |
Synta Pharmaceuticals Corp. |
Combination therapy of Hsp90 inhibitors with platinum-containing agents
|
|
WO2013074594A1
(en)
|
2011-11-14 |
2013-05-23 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with braf inhibitors
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
JO3407B1
(ar)
*
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
US10092574B2
(en)
|
2012-09-26 |
2018-10-09 |
Valorisation-Recherche, Limited Partnership |
Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
|
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
抗糖尿病二環式化合物
|
|
JP6364031B2
(ja)
|
2013-03-13 |
2018-07-25 |
ユニリーバー・ナームローゼ・ベンノートシヤープ |
パーソナルケア組成物からのある芳香剤構成成分の長期送達
|
|
EP2968094B1
(en)
|
2013-03-13 |
2018-05-30 |
Unilever PLC |
Photoprotective compositions with tricyclodecane amides
|
|
BR112015022117A2
(pt)
|
2013-03-13 |
2017-07-18 |
Unilever Nv |
precursor da composição cosmética, composição cosmética para a aplicação tópica, método para a administração de um agente cosmético sólido e amida de triciclodecano
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
JP6064062B2
(ja)
|
2013-03-15 |
2017-01-18 |
ファイザー・インク |
Ａｍｐｋを活性化させるインダゾール化合物
|
|
CN103420931B
(zh)
*
|
2013-05-02 |
2015-07-08 |
范国煌 |
调节巨噬细胞极化并抗糖尿病的五环化合物及其应用
|
|
GB201317363D0
(en)
|
2013-10-01 |
2013-11-13 |
Eisai Ltd |
Novel compounds
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
JP6434980B2
(ja)
|
2013-12-09 |
2018-12-05 |
ユニリーバー・ナームローゼ・ベンノートシヤープ |
アダマンタンアミド製造方法
|
|
US9381171B2
(en)
|
2013-12-19 |
2016-07-05 |
Samsung Electronics Co., Ltd. |
Composition including dapsone for preventing or treating side effect of steroid in subject and use of the composition
|
|
HRP20210935T1
(hr)
|
2014-05-23 |
2021-08-06 |
F. Hoffmann - La Roche Ag |
Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak
|
|
KR102529578B1
(ko)
*
|
2014-08-29 |
2023-05-09 |
(주)아모레퍼시픽 |
신규 아다만탄 유도체 화합물
|
|
EA201790806A1
(ru)
|
2014-11-05 |
2017-11-30 |
Флексус Байосайенсиз, Инк. |
Иммунорегулирующие средства
|
|
UY36390A
(es)
*
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
|
TWI746426B
(zh)
|
2014-11-16 |
2021-11-21 |
美商亞雷生物製藥股份有限公司 |
(S)-N-(5-((R)-2-(2,5-二氟苯基)-吡咯啶-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羥基吡咯啶-1-甲醯胺硫酸氫鹽結晶型
|
|
EP3368039A1
(en)
|
2015-10-26 |
2018-09-05 |
The Regents of The University of Colorado, A Body Corporate |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
WO2017123826A1
(en)
|
2016-01-14 |
2017-07-20 |
Beth Israel Deaconess Medical Center, Inc. |
Mast-cell modulators and uses thereof
|
|
UA125026C2
(uk)
|
2016-04-04 |
2021-12-29 |
Локсо Онколоджі, Інк. |
РІДКІ КОМПОЗИЦІЇ (S)-N-(5-((R)-2-(2,5-ДИФТОРФЕНІЛ)ПІРОЛІДИН-1-ІЛ)ПІРАЗОЛО[1,5-a]ПІРИМІДИН-3-ІЛ)-3-ГІДРОКСИПІРОЛІДИН-1-КАРБОКСАМІДУ
|
|
UA125025C2
(uk)
|
2016-04-04 |
2021-12-29 |
Локсо Онколоджі, Інк. |
Способи лікування дитячих ракових захворювань
|
|
MX392604B
(es)
|
2016-05-18 |
2025-03-24 |
Array Biopharma Inc |
Procesos para la preparacion de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidin-1-carboxamida y sales del mismo.
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
WO2018086531A1
(zh)
*
|
2016-11-08 |
2018-05-17 |
正大天晴药业集团股份有限公司 |
作为cccDNA抑制剂的磺酰胺类化合物
|
|
EP3548035A4
(en)
|
2016-11-30 |
2020-07-22 |
Case Western Reserve University |
COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
CN110573154A
(zh)
|
2017-02-06 |
2019-12-13 |
卡斯西部储备大学 |
调节短链脱氢酶活性的组合物和方法
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
JP7178360B2
(ja)
|
2017-04-07 |
2022-11-25 |
ケース ウエスタン リザーブ ユニバーシティ |
冠状動脈障害を治療するための短鎖型デヒドロゲナーゼ活性の阻害剤
|
|
JP7256757B2
(ja)
|
2017-05-22 |
2023-04-12 |
エフ． ホフマン－ラ ロシュ アーゲー |
処置用化合物及び組成物、並びにその使用方法
|
|
WO2020106998A1
(en)
|
2018-11-21 |
2020-05-28 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
TW202043205A
(zh)
|
2018-12-31 |
2020-12-01 |
美商拜歐米富士恩有限公司 |
Menin-mll相互作用之抑制劑
|
|
WO2020142557A1
(en)
|
2018-12-31 |
2020-07-09 |
Biomea Fusion, Llc |
Irreversible inhibitors of menin-mll interaction
|
|
JP7730807B2
(ja)
*
|
2019-09-04 |
2025-08-28 |
エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ |
β－カテニン／ＴＣＦ４相互作用のモジュレーターとしての複素環化合物
|
|
AU2020380926B2
(en)
*
|
2019-11-05 |
2026-07-16 |
Dermira, Inc. |
MrgprX2 antagonists and uses thereof
|
|
US20230029266A1
(en)
|
2019-11-05 |
2023-01-26 |
Dermira, Inc. |
MrgprX2 Antagonists for the Treatment of Inflammatory Disorders
|
|
AU2021224268A1
(en)
|
2020-02-21 |
2022-09-15 |
Case Western Reserve University |
Compositions and methods for treating renal injury
|
|
JP7891524B2
(ja)
|
2021-08-11 |
2026-07-16 |
バイオメア フュージョン，インコーポレイテッド |
真性糖尿病に対するメニン－ｍｌｌ相互作用の共有結合性阻害剤
|
|
MX2024002189A
(es)
|
2021-08-20 |
2024-06-11 |
Biomea Fusion Inc |
Forma cristalina de n-[4-[4-(4-morfolinil)-7h-pirrolo[2,3-d]pirimi din-6-il]fenil]-4-[[3(r)-[(1-oxo)-2-propen-1-il)amino]-1-piperidi nil]metil]-2-piridinacarboxamida, un inhibidor irreversible de menina-mll para el tratamiento del cancer.
|
|
WO2024155719A1
(en)
|
2023-01-18 |
2024-07-25 |
Biomea Fusion, Inc. |
Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2- pyridinecarboxamide as a covalentinhibitor of menin-mll interaction
|
|
KR102863193B1
(ko)
*
|
2023-03-13 |
2025-09-22 |
대구가톨릭대학교산학협력단 |
리도카인 유도체를 유효성분으로 포함하는 항염증용 조성물
|
|
EP4458358A1
(en)
*
|
2023-05-02 |
2024-11-06 |
Tietze Chemical Consulting UG |
Pyridazine compounds for antifibrotic therapy
|
|
WO2025002289A1
(zh)
*
|
2023-06-29 |
2025-01-02 |
湖南九典制药股份有限公司 |
一种吡唑并杂芳基类化合物及其制备方法和应用
|
|
WO2025213050A1
(en)
*
|
2024-04-05 |
2025-10-09 |
Albert Einstein College Of Medicine |
Inhibitors of chaperone-mediated autophagy and their therapeutic uses
|